Skip to content

SpyGlass Pharma

US · SGP #3415 by market cap Listed 2026
30.43 -0.35 -1.14%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

After-hours 30.43 0.00%
38.3717.5630.432026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on SGP?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +16.0% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 3.5% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -7.45%
1M +16.32%
3M +16.01%
6M +39.01%

Key statistics

Price & volume

Prev close
30.78
Open
30.12
Day range
29.07 - 31.73
Avg price
30.88
Volume
108.91K
Turnover
3.36M
Amplitude
8.66%
52-week range
17.06 - 39.92

Valuation

P/E
-25.51
P/E (TTM)
-14.44
P/B
4.84
EPS
-1.19
Net profit
-39.92M
Net assets
210.44M

Share structure

Market cap
1.02B
Float cap
197.69M
Shares out
33.46M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2026-02-06
52-week range 58% of range
17.06 39.92

23.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+79.12K net over the window

Short interest

Shares short
1.16M
As of
2026-10-30

Frequently asked questions

What is the current stock price of SpyGlass Pharma (SGP)?

SpyGlass Pharma last traded at 30.43. This page shows a periodic quote snapshot. Check the displayed quote time.

What is SpyGlass Pharma's market cap?

About 1.02B.

What is the P/E ratio of SpyGlass Pharma?

The trailing twelve-month P/E is -14.44. The Valuation tab shows it against the stock's own five-year range.

Does SpyGlass Pharma pay a dividend?

SpyGlass Pharma does not currently pay a regular dividend.

Is SpyGlass Pharma a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 44.00, which implies 44.6% upside from the current price. This is not investment advice.

What is SpyGlass Pharma's StockVane Quant Rating?

The StockVane Momentum strategy currently rates SpyGlass Pharma a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

SpyGlass Pharma discussion 0 comments

Add a comment